GLP-1 drugs such as Ozempic and Wegovy now cost the Montgomery County Public Schools employee health plan “over $100 million,” MCPS’s chief financial officer told a school board committee in September, and MCPS later told Moderately MOCO that the figure is before drug-maker rebates. In a Novo Nordisk-funded trial of
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.